术前免疫预后指数良好可预测老年II期胃癌腹腔镜胃切除术后长期结局优于开腹手术
本研究纳入1539例接受根治性胃切除术的老年胃癌患者,经倾向性评分匹配1:1比较腹腔镜与开腹手术,基于dNLR和sLDH构建免疫预后指数(IPI)。结果显示IPI与长期预后相关;在IPI=0的II期老年胃癌中,腹腔镜手术较开腹手术与更长的5年总生存和无进展生存相关,但需前瞻性研究证实。
要点
- IPI由dNLR和sLDH构建,评分0为良好,1或2为不良。
- IPI=0的II期老年胃癌,腹腔镜手术较开腹手术5年OS和PFS更长。
- IPI=1或I、III期患者中,腹腔镜与开腹手术的OS和PFS无显著差异。
核心结论
- IPI与老年胃癌长期预后相关;在IPI良好的II期老年胃癌中,腹腔镜手术可能较开腹手术改善5年生存率。
主要发现
- 匹配后共528例(腹腔镜264例,开腹264例),IPI=0组271例,IPI=1组257例。
- 整个队列中,IPI=0组较IPI=1组5年总生存(p=0.001)和无进展生存(p=0.003)更好;腹腔镜与开腹组间5年OS和PFS无显著差异。
- IPI=1队列中,各肿瘤分期下腹腔镜与开腹组的OS或PFS均无显著差异。
- IPI=0队列中,II期老年胃癌患者腹腔镜手术较开腹手术OS更长(p=0.015)、PFS更长(p=0.018),I期或III期无此差异。
- 多因素分析显示IPI=0是II期老年胃癌接受腹腔镜手术的独立保护因素,对开腹手术患者则不是。
临床怎么用
- 对老年胃癌患者可考虑检测术前dNLR和sLDH计算IPI,辅助评估长期预后。
- IPI良好(评分0)的II期老年胃癌患者,腹腔镜手术可能带来更优的5年生存获益。
局限性
- 为回顾性研究,结论需前瞻性研究进一步证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It remains inconclusive whether laparoscopic gastrectomy (LG) has better long-term outcomes when compared with open gastrectomy (OG) for elderly gastric cancer (EGC). We attempted to explore the influence of the immune prognostic index (IPI) on the prognosis of EGCs treated by LG or OG to identify a population among EGC who may benefit from LG. METHODS: We included 1539 EGCs treated with radical gastrectomy from January 2007 to December 2016. Propensity score matching was applied at a ratio of 1:1 to compare the LG and OG groups. The IPI based on dNLR ≥ cut-off value (dNLR) and sLDH ≥ cut-off value (sLDH) was developed, characterizing two groups (IPI = 0, good, 0 factors; IPI = 1, poor, 1 or 2 factors). RESULTS: Of the 528 EGCs (LG: 264 and OG: 264), 271 were in the IPI = 0 group, and 257 were in the IPI = 1 group. In the entire cohort, the IPI = 0 group was associated with good 5-year overall survival (OS) (p = 0.001) and progression-free survival (PFS) (p = 0.003) compared to the IPI = 1 group; no significant differences in 5-year OS and PFS between the LG and OG groups were observed. In the IPI = 1 cohort, there was no significant difference in OS or PFS between the LG and OG groups across all tumor stages. However, in the IPI = 0 cohort, LG was associated with longer OS (p = 0.015) and PFS (p = 0.018) than OG in stage II EGC, but not in stage I or III EGC. Multivariate analysis showed that IPI = 0 was an independent protective factor for stage II EGC receiving LG, but not for those receiving OG. CONCLUSION: The IPI is related to the long-term prognosis of EGC. Compared with OG, LG may improve the 5-year survival rate of stage II EGC with a good IPI score. This hypothesis needs to be further confirmed by prospective studies.
引用
- Lin GS, Huang XY, Lu J, et al. A good preoperative immune prognostic index is predictive of better long-term outcomes after laparoscopic gastrectomy compared with open gastrectomy for stage II gastric cancer in elderly patients. Surg Endosc. 2021. PMID: 34076769. doi:10.1007/s00464-021-08461-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。